Lyra Therapeutics reported cash from operations of -$6.07M and free cash flow of -$6.12M for the quarter ended Dec 2025, up 46.6% year over year. This cash flow statement covers 28 quarters of results from Mar 2019 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -7.80M | -11.04M | -11.05M | -13.62M | -11.91M | -14.37M | -14.77M | -14.22M | -16.25M | -15.62M | -15.65M | -15.16M | -22.45M | -48.13M | -11.87M | 8.67M | -8.55M | -7.44M | -5.98M | -0.87M | ||||||||
| Share-based Compensation | 1.76M | 1.76M | 1.85M | 0.78M | 2.96M | 4.02M | 4.34M | 1.76M | 5.50M | 5.87M | 5.84M | 13.75M | 13.67M | 7.05M | 6.39M | 4.74M | 0.91M | 0.07M | 0.56M | |||||||||
| Asset Writedowns and Impairment | 1.59M | 0.01M | 1.88M | 0.02M | ||||||||||||||||||||||||
| Cash from Restructuring | 1.73M | -0.51M | -0.31M | -0.55M | -0.43M | 0.21M | ||||||||||||||||||||||
| Cash from Operations | -7.59M | 3.38M | -10.31M | -11.30M | -11.90M | -8.47M | -10.85M | -12.16M | -15.85M | -14.28M | -14.11M | -19.06M | -22.45M | -19.98M | -16.22M | -11.35M | -8.84M | -6.59M | -7.36M | -6.07M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.73M | 0.63M | 1.06M | 1.09M | 0.93M | 0.68M | 0.40M | 0.27M | ||||||||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Account Payables | 0.45M | 0.29M | 0.42M | 1.18M | -0.66M | -0.98M | 1.47M | -2.24M | 3.29M | -0.11M | 0.80M | -3.54M | -0.56M | 2.38M | -2.59M | -1.11M | -0.45M | -0.04M | -0.12M | 0.10M | ||||||||
| Change in Accured Expenses | -0.98M | 0.96M | 0.99M | 0.28M | -0.09M | 1.29M | 1.61M | 1.96M | -2.32M | -0.61M | 2.30M | 2.12M | 0.83M | -3.33M | -2.90M | -0.57M | -0.34M | -0.20M | -0.94M | -0.33M | ||||||||
| Other Working Capital Changes | -0.24M | -0.24M | 1.91M | -2.42M | -0.37M | -0.42M | -0.01M | 1.56M | -0.84M | -0.29M | 0.28M | -0.35M | -0.59M | -0.86M | -0.98M | -0.94M | -1.02M | -0.88M | -1.10M | -1.12M | ||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital Expenditures | 1.16M | 0.62M | 0.52M | 1.08M | 0.09M | 0.01M | 0.03M | 0.03M | 0.04M | 0.07M | 0.14M | 0.79M | 2.15M | 0.20M | 0.05M | -0.06M | 0.05M | 0.05M | ||||||||||
| Change in Acquisitions & Divestments | 9.80M | 25.00M | 28.00M | 48.09M | 30.53M | 50.99M | 21.00M | 28.07M | ||||||||||||||||||||
| Cash from Investing Activities | -1.16M | -0.62M | -0.52M | -1.08M | -0.09M | -0.01M | -0.03M | -64.87M | 5.32M | -0.56M | -14.98M | -2.36M | 7.86M | 36.18M | 8.14M | 28.13M | -0.10M | |||||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activities | 0.26M | 0.33M | 0.01M | 0.01M | 0.00M | 0.10M | 0.00M | 0.00M | ||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.37M | 0.43M | 1.30M | 2.83M | 1.42M | 1.86M | 2.35M | 2.61M | 1.80M | 0.06M | ||||||||||||||||||
| Net Equity Issued and Repurchased | ||||||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||
| Cash from Financing Activities | 0.26M | 0.18M | -0.08M | -0.00M | 0.01M | 96.49M | -0.24M | 0.00M | 47.19M | -0.42M | 18.92M | 8.64M | -0.09M | -0.02M | -0.00M | -0.37M | ||||||||||||
| Change in Cash | -8.49M | 2.94M | -10.91M | -12.38M | -11.99M | 88.00M | -11.11M | -77.03M | -10.53M | 32.34M | -29.51M | -2.50M | -5.95M | 16.11M | -8.11M | 16.78M | -8.84M | -1.95M | -7.73M | -6.16M | ||||||||
| Free Cash Flow | -8.75M | 2.76M | -10.83M | -12.38M | -12.00M | -8.48M | -10.88M | -12.19M | -15.89M | -14.35M | -14.26M | -19.84M | -24.60M | -20.18M | -16.27M | -11.29M | -8.84M | -6.59M | -7.41M | -6.12M | ||||||||
| Net Cash Flow | -8.49M | 2.94M | -10.91M | -12.38M | -11.99M | 88.00M | -11.11M | -77.03M | -10.53M | 32.34M | -29.51M | -2.50M | -5.95M | 16.11M | -8.11M | 16.78M | -8.84M | -6.59M | -7.73M | -6.16M |